186 related articles for article (PubMed ID: 11101805)
1. Enhanced major histocompatibility complex class I-dependent presentation of antigens modified with cationic and fusogenic peptides.
Laus R; Graddis TJ; Hakim I; Vidovic D
Nat Biotechnol; 2000 Dec; 18(12):1269-72. PubMed ID: 11101805
[TBL] [Abstract][Full Text] [Related]
2. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.
Rodriguez A; Regnault A; Kleijmeer M; Ricciardi-Castagnoli P; Amigorena S
Nat Cell Biol; 1999 Oct; 1(6):362-8. PubMed ID: 10559964
[TBL] [Abstract][Full Text] [Related]
3. Enhanced generation of cytotoxic T lymphocytes by increased cytosolic delivery of MHC class I epitope fused to mouse heat shock protein 70 via polyhistidine conjugation.
Takemoto S; Nishikawa M; Otsuki T; Yamaoka A; Maeda K; Ota A; Takakura Y
J Control Release; 2009 Apr; 135(1):11-8. PubMed ID: 19100299
[TBL] [Abstract][Full Text] [Related]
4. On cross-priming of MHC class I-specific CTL: rule or exception?
Zinkernagel RM
Eur J Immunol; 2002 Sep; 32(9):2385-92. PubMed ID: 12207322
[No Abstract] [Full Text] [Related]
5. Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo.
Schirmbeck R; Böhm W; Reimann J
Eur J Immunol; 1994 Sep; 24(9):2068-72. PubMed ID: 8088327
[TBL] [Abstract][Full Text] [Related]
6. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
[TBL] [Abstract][Full Text] [Related]
7. OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway.
Jeannin P; Renno T; Goetsch L; Miconnet I; Aubry JP; Delneste Y; Herbault N; Baussant T; Magistrelli G; Soulas C; Romero P; Cerottini JC; Bonnefoy JY
Nat Immunol; 2000 Dec; 1(6):502-9. PubMed ID: 11101872
[TBL] [Abstract][Full Text] [Related]
8. Dynamic quantification of MHC class I-peptide presentation to CD8+ T cells via intracellular cytokine staining.
Pang KC; Wei JQ; Chen W
J Immunol Methods; 2006 Apr; 311(1-2):12-8. PubMed ID: 16516224
[TBL] [Abstract][Full Text] [Related]
9. Enhanced CTL response by controlled intracellular trafficking of antigen in dendritic cells following DNA vaccination.
Isaji K; Kawase A; Matono M; Guan X; Nishikawa M; Takakura Y
J Control Release; 2009 May; 135(3):227-33. PubMed ID: 19331843
[TBL] [Abstract][Full Text] [Related]
10. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
Hao S; Yuan J; Xiang J
J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
[TBL] [Abstract][Full Text] [Related]
11. Cross-presentation: underlying mechanisms and role in immune surveillance.
Rock KL; Shen L
Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
[TBL] [Abstract][Full Text] [Related]
12. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
Hetttihewa LM
Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436
[TBL] [Abstract][Full Text] [Related]
13. Induction of cytotoxic T lymphocytes following immunization with cationized soluble antigen.
Ikenaga T; Yamasaki Y; Shakushiro K; Nishikawa M; Takakura Y
Vaccine; 2004 Jun; 22(20):2609-16. PubMed ID: 15193386
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of major histocompatibility complex Class I antigen presentation by hepatitis C virus core protein in myeloid dendritic cells.
O'Beirne J; Mitchell J; Farzaneh F; Harrison PM
Virology; 2009 Jun; 389(1-2):1-7. PubMed ID: 19409594
[TBL] [Abstract][Full Text] [Related]
15. Delivery of protein antigen to the major histocompatibility complex class I-restricted antigen presentation pathway.
Zhou F; Huang L
J Drug Target; 1995; 3(2):91-109. PubMed ID: 7496732
[TBL] [Abstract][Full Text] [Related]
16. Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide.
Kim DT; Mitchell DJ; Brockstedt DG; Fong L; Nolan GP; Fathman CG; Engleman EG; Rothbard JB
J Immunol; 1997 Aug; 159(4):1666-8. PubMed ID: 9257826
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen.
Sigal LJ; Crotty S; Andino R; Rock KL
Nature; 1999 Mar; 398(6722):77-80. PubMed ID: 10078533
[TBL] [Abstract][Full Text] [Related]
18. CpG-DNA aided cross-presentation of soluble antigens by dendritic cells.
Maurer T; Heit A; Hochrein H; Ampenberger F; O'Keeffe M; Bauer S; Lipford GB; Vabulas RM; Wagner H
Eur J Immunol; 2002 Aug; 32(8):2356-64. PubMed ID: 12209649
[TBL] [Abstract][Full Text] [Related]
19. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
20. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.
Radford KJ; Turtle CJ; Kassianos AJ; Hart DN
J Immunother; 2006; 29(6):596-605. PubMed ID: 17063122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]